Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |